News of Note—Boehringer expands China CDMO operation

news of note
(Pixabay)

> Germany's Boehringer Ingelheim is adding a bioreactor to its CDMO operation in China in anticipation of producing a monoclonal antibody at the facility this year. Release 

> The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is providing $32 million in grants for a long list of projects designed to improve biopharmaceutical manufacturing technology. Release

> MedPharm is investing $4 million to triple the size of its facility in Durham, North Carolina, for formulation development and performance testing of topical and transdermal medicines as well as increasing its LC/MS capacity and the automation of sample handling. Release

Free Webinar

Striving for Zero in Quality & Manufacturing

Pharmaceutical and medical device manufacturers strive towards a culture of zero – zero hazards, zero defects, and zero waste. This webinar will discuss the role that content management plays in pharmaceutical manufacturing to help companies reach the goal of zero in Quality and Manufacturing.

> The European Medicines Agency has reinstated the GMP manufacturing certificate to the Bristol Laboratories plant in Luton after a follow-up inspection found it had resolved issues raised in 2017. Report

Suggested Articles

The cleaning procedures are so poor at a Zydus Cadila plant in India that the FDA says a sampling found 10 different cross-contaminated products.

Mylan is the most recent drugmaker facing the FDA's ire over a tainted API that led to a global recall of "sartan"-based drugs last year.

Merck MSD's $1.2 billion production restructuring has fallen on a site in France, where more than 200 manufacturing and R&D jobs will be swept away.